Seraphim Space Investment Trust (LSE: SSIT) leans on ICEYE re-rating and SpaceX IPO tailwind to consolidate FTSE 250 entry
Read More Pharma Industry News Investors watch Nuvalent ahead of pivotal neladalkib ALKOVE-1 topline data in resistant ALK-positive NSCLC Nuvalent will unveil pivotal ALKOVE-1 data for neladalkib in TKI-pretreated ALK-positive NSCLC on November 17. Explore why investors believe this readout could redefine targeted lung cancer care. bySoujanya RaviNovember 15, 2025